ANTERIOR PLACENTA POSITION AS A CAUSING FACTOR OF PRE-ECLAMPSIA

Authors

  • L. I. Berlinska Odesa National Medical University
  • V. G. Marichereda Odesa National Medical University
  • O. M. Pavlovska Odesa National Medical University
  • Y. Y. Petrovskiy Odesa National Medical University

DOI:

https://doi.org/10.11603/24116-4944.2020.2.11862

Keywords:

preeclampsia, anterior location of the placenta, cystatin C, screening

Abstract

The aim of the study – to determine the frequency of preeclampsia in pregnant females with anterior location of the placenta and to determine the prognostic significance when combined with a marker of acute renal damage – cystatin C level.

Materials and Methods. In 2018–2020, a prospective cohort study that enrolled 91 pregnant women at their second trimester of gestation was conducted at Maternity Clinic and Obstetric Hospital of Maternity Hospital No. 2, Odesa. The group with the anterior location of the placenta consisted of 47 (51.65 %) pregnant women and 44 (48.35 %) had the posterior location of the placenta. Assessment of serum cystatin C was performed in women without clinical manifestations of PE at the second or third trimester of gestation (18–36 weeks), the average term was (32.22±0.41) weeks of pregnancy (p=0.011).

Results and Discussion. 28.57 % of pregnant women were subsequently diagnosed with preeclampsia (PE), of whom 19 (20.88 %) had anterior and 7 (7.69 %) posterior placenta location. Body mass index (BMI) before pregnancy, age, and height: no statistically significant difference observed between groups (p> 0.05). Analysis of maternal factors of PE in relation to the anterior location of the placenta: odds ratio (OR) higher than 1.0 was noted for combination with obesity (OR 2.38 (95 % CI 0.75–7.53)), the age over 35 years (OR 1.01 (95 % CI 0.41–2.49)) and history of PE during previous pregnancy (OR 1.38 (95 % CI 0.21–9.01)), but no statistical significance was observed (р˃0.05). When analyzing cystatin C values over 1.0 mmol/l relative to the anterior location of the placenta, the OR was 3.92 (95 % CI 1.45–10.57), sensitivity 84.09 %, specificity 42.55 %, accuracy 62.64 % were reported, p=0.011. When analyzing the frequency of preeclampsia in the anterior location of the placenta, the OR was 3.59 (95 % CI 1.32 - 9.71), sensitivity 84.09 %, specificity 40.43 %, accuracy 61.54 % were reported with statistical significance p=0.019.

Conclusions. The risk of preeclampsia in patients with the anterior location of the placenta increases by 3.59 times with a prognostic accuracy of 61.54 %. To increase the prognostic significance for the detection of preeclampsia in women with anterior location of the placenta, it is recommended to assess the serum level of cystatin C.

Author Biographies

L. I. Berlinska, Odesa National Medical University

MD, Associate Professor, Department of Obstetrics and Gynecology, Odessa National Medical University

V. G. Marichereda, Odesa National Medical University

Doctor of Medical Sciences, Professor of the Department of Obstetrics and Gynecology No. 1, Vice-Rector for Research, Odessa National Medical University

O. M. Pavlovska, Odesa National Medical University

Candidate of Medical Sciences, urologist of the consultative-diagnostic polyclinic department of the multidisciplinary medical center of Odessa National Medical University, leading specialist, Training and production complex of innovative technologies of training, informatization, continuing education and internal monitoring of the quality of education of Odessa National Medical University

Y. Y. Petrovskiy, Odesa National Medical University

Candidate of Medical Sciences, Associate Professor of the Department of Obstetrics and Gynecology, Odessa National Medical University

References

Poon, L.C., Shennan, A., Hyett, J.A., Kapur, A., Hadar, E., Divakar, H., …, & Hod, M. (2019). The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int. J. Gynecol. Obstet., 145 (S1), 1-33. DOI:10.1002/ijgo.12802.

Sotiriadis, A., Hernandez-Andrade, E., da Silva Costa, F., Ghi, T., Glanc, P., Khalil, A., …, & Thilaganathan, B. (2019). ISUOG Practice Guidelines: role of ultrasound in screening for and follow-up of pre-eclampsia. Ultrasound. Obstet. Gynecol., 53 (1), 7-22. DOI:10.1002/uog.20105.

Khong, L.S., Kane, C.S, Brennecke, P.S, & da Silva Costa, F. (2015). First-trimester uterine artery doppler analysis in the prediction of later pregnancy complications. Dis. Markers. DOI:10.1155/2015/679730.

O'Gorman, N., Wright, D., Poon, L.C., Rolnik, D.L., Syngelaki, A., Wright, A., …, & Nicolaides, K.H. (2017). Accuracy of competing-risks model in screening for pre-eclampsia bymaternal factors and biomarkers at 11-13 weeks’gestation. Ultrasound. Obstet. Gynecol, 49, 751-755. DOI:10.1002/uog.17399.

Rana, S., Lemoine, E., Granger, J.P., & Karumanchi, S.A. (2019). Preeclampsia pathophysiology, challenges, and perspectives. Circ. Res., 124 (7), 1094-1112. DOI:10.1161/CIRCRESAHA.118.313276.

Ojha, K., Rawal, S., & Jha, A. (2018). Placental pathology in severe pre-eclampsia and eclampsia. Nep. Med. J., 1 (1), 32-35.

Brown, M.A., Magee, L.A., Kenny, L.C. , Karumanchi, S.A., McCarthy, F.P., Saito, S., …, & Ishaku, S. (2018). The hypertensive disorders of pregnancy: ISSHP classification, diagnosis and management recommendations for international practice. Pregnancy Hypertens., 13, 291-310. DOI:10.1016/j.preghy.2018.05.004.

Marichereda, V.G., Holubenko, M.Yu., & Berlinska, L.I. (2020). Priorytetnist cystatynu C pomizh nyrkovyx biomarkeriv v diagnostyci preeklampsiyi [Priority of cystatin C among other renal biomarkers for pre-eclampsia diagnosing]. Počki – Kidney, 9 (2), 87-91. DOI:10.22141/2307-1257.9.2.2020 [in Ukrainian].

Feig D.S., Shah B.R., Lipscombe L.L., Wu C.F., Ray J.G. et al. (2013) Preeclampsia as a risk factor for diabetes: a population-based cohort study. PLoS Med., 10 (4), e1001425. DOI:10.1371/journal.pmed.1001425.

Bergen, N.E., Schalekamp-Timmermans, S., Roos-Hesselink, J., Roeters van Lennep, J.E., Jaddoe, V.V.W., & Steegers, E.A.P. (2018). Hypertensive disorders of pregnancy and subsequent maternal cardiovascular health. Eur. J. Epidemiol., 33, 763-771. DOI:10.1007/s10654-018-0400-1.

Lopes, V.A., Spaan, J.J., & Cornelis, T. (2017). Prevalence of chronic kidney disease after preeclampsia. J. Nephrol., 30, 403-409. DOI:10.1007/s40620-016-0342-1.

Chaudhry, R., & Chaudhry, K. (2020). Anatomy, abdomen and pelvis, uterine arteries. Treasure Island (FL): StatPearls Publishing, 2020.

Kozlov, S.V., Dvoretskii, D.D., Alekseenko, L.A., Omelchenko, A., & Kartamysheva, V.D. (2018). Variantnaya anatomiya arteriy matki [Anatomical variants of uterine arteries]. Ukrainskyi zhurnal medytsyny, biolohii ta sportu – Ukrainian Journal of Medicine, Biology and Sport, 3, 4 (13), 32-37 [in Russian].

Nair, V.V., Nair, S.S., & Radhamany, K. (2019). Study of placental location and pregnancy outcome. Int. J. Reprod. Contracept. Obstet. Gynecol., 8 (4), 1393-1397.

Prathima, A., & Reddi Rani, P. (2019). Association of placental position with the development of hypertension in pregnancy. Int. J. Reprod. Contracept. Obstet. Gynecol., 8 (1), 238-242.

Keshavarz, E., Sadeghian, A., Hakemi, A.G., & Khtibi, F.T. (2017). Prediction of pre-eclampsia development by placenta location: a simple predictor. J. Obstet. Gynecol. Cancer. Res., 2 (4), e11945.

Priyadarshini, A., Upreti, P., Nautiyal, R., & Goyal, M. (2019). Placental location and development of preeclampsia: a longitudinal study. Int. J. Reprod. Contracept. Obstet. Gynecol., 8 (4), DOI:10.18203/2320-1770.ijrcog20191005.

Sandhya, K., Madhavi, G.B., & Chandramathi, M. (2015). Placental laterality as a predictor of preeclampsiа. Am. J. Phytomed. Clin. Ther., 3 (3), 231-236. DOI:10.1007/s13224-012-0241-x.

Rai, A., Thatal, A., Sharma, B.K., & Narwat, Y. (2020). Lateral placenta as a predictor for development of preeclampsia. Indian J. Obstet. Gynecol. Res., 7 (2), 216-221.

Salama-Bello, R., Duncan, J.R., Howard, S.L., Song, J., & Schenone, M.H. (2019). Placental location and the development of hypertensive disorders of pregnancy. J. Ultrasound. Med., 38, 173-177. DOI:10.1002/jum.14681.

Jenabi, E., Veisani, Y., & Khazae, S. (2020). The association between placenta previa and pre-eclampsia: a meta-analysis. Erciyes Med. J., 42 (1), 3-6.

Zia, S. (2013). Placental location and pregnancy outcome. J. Turkish-German Gynecol. Assoc., 14, 190-193. DOI:10.5152/jtgga.2013.92609.

Belachewa, J., Eureniusa, K., Mulic-Lutvicaa, A., & Axelsson, O. (2017). Placental location, postpartum hemorrhage and retained placenta in women with a previous cesarean section delivery: a prospective cohort study. Upsala J. Med. Sci., 122 (3), 185-189. DOI: 10.1080/03009734.2017.1356405.

Marichereda, V.G., Gladchuk, I.Z., & Berlinska, L.I. (2019). Znachushhist tsystatynu C v doklinichnii diahnostytsi preeklampsii u vahitnykh [The significance of cystatine С in pre-clinical diagnosing of pre-eclampsia in pregnant women]. Aktualni pytannia pediatrii, akusherstva ta hinekolohii – Actual Problems of Pediatrics, Obstetrics and Gynecology, 2, 133-137. DOI:10.11603/24116-4944.2019.2.10933 [in Ukrainian].

Published

2021-03-04

How to Cite

Berlinska, L. I., Marichereda, V. G., Pavlovska, O. M., & Petrovskiy, Y. Y. (2021). ANTERIOR PLACENTA POSITION AS A CAUSING FACTOR OF PRE-ECLAMPSIA. Actual Problems of Pediatrics, Obstetrics and Gynecology, (2), 191–196. https://doi.org/10.11603/24116-4944.2020.2.11862

Issue

Section

OBSTETRICS AND GYNECOLOGY